1. A look at the world from inside the toxicologist's cage

   • G. Zbinden

   Personal Opinion Pages: 333 - 338

2. Cardiovascular response to exercise under increasing doses of chlorthalidone

   • R. I. Ogilvie

   Originals Pages: 339 - 344

3. Metabolism of digitoxin in man and its modification by spironolactone

   • K. E. Wirth
   • J. C. Frölich
   • J. A. Oates

   Originals Pages: 345 - 354

4. Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent — Minoxidil

   • K. O'Malley
   • M. Velasco
   • J. McNay

   Originals Pages: 355 - 360

5. A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol

   • L. Hansson
   • A. Westerlund
   • B. E. Karlberg

   Originals Pages: 361 - 365

6. Observations on the efficacy and pharmacokinetics of sotalol after oral administration

   • H. C. Brown
   • S. G. Carruthers
   • R. G. Shanks

   Originals Pages: 367 - 372

7. Bioavailability and pharmacokinetics of β- methyldigoxin after multiple oral and intravenous doses

   • N. Rietbrock
   • J. Guggenmos
   • U. Hess

   Originals Pages: 373 - 379

8. Antagonism of endogenous mineralocorticoids in normal subjects by prorenoate potassium and spironolactone

   • D. Levine
   • L. Ramsay
   • M. Tidd

   Originals Pages: 381 - 386

9. Arwin^® in peripheral arterial circulatory disorders: Controlled multicentre trials

   • G. K. Wolf

   Originals Pages: 387 - 392

10. A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

    • C. Grassi
    • G. C. Morandini

    Originals Pages: 393 - 396

11. Comparative clinical pharmacology of intravenous cefoxitin and cephalothin

    • P. F. Sonneville
    • R. R. Kartodirdjo
    • C. M. Martin

    Originals Pages: 397 - 403

12. Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis

    • K. M. Goebel
    • R. Janzen
    • U. Börngen

    Originals Pages: 405 - 410

13. Effect of paracetamol, mephenoxalone and their combination on pain following bone surgery

    • J. Eskenazi
    • T. Nikiforidis
    • J. L. Schelling

    Originals Pages: 411 - 415

14. Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy

    • M. Eichelbaum
    • L. Bertilsson
    • F. Sjöqvist

    Originals Pages: 417 - 421

15. Some aspects of the intestinal absorption of zinc in man

    • K. -E. Andersson
    • L. Bratt
    • E. Lanner

    Originals Pages: 423 - 428

16. Decreased drug binding in serum from patients with chronic hepatic disease

    • S. Wallace
    • M. J. Brodie

    Originals Pages: 429 - 432

17. Comparison of the acetylation of procainamide and sulfadimidine in man

    • K. Frislid
    • M. Berg
    • P. K. M. Lunde

    Originals Pages: 433 - 438

18. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbutamide in man

    • T. Lysbo Svendsen
    • M. Brandt Kristensen
    • L. Skovsted

    Originals Pages: 439 - 441

19. Pharmacokinetics and relative bioavailability of cyclobarbital calcium in man after oral administration

    • D. D. Breimer
    • M. A. C. M. Winten

    Originals Pages: 443 - 450

20. Determination of therapeutic serum concentrations of oral and parenteral meperidine by gas liquid chromatography

    • A. P. L. Shih
    • K. Robinson
    • W. Y. W. Au

    Originals Pages: 451 - 456

21. Measurement of plasma levels of tricyclic psychoactive drugs and their metabolites by UV reflectance photometry of thin layer chromatograms

    • U. Breyer
    • K. Villumsen

    Originals Pages: 457 - 465

22. Advice to advisers?

    • F. Gross

    Editorial Pages: 467 - 468

23. International co-operation in drug testing

    • T. B. Binns
    • Franz Gross
    • F. B. Nicolis

    Special Article Pages: 469 - 470

24. Information

    Announcement Pages: 470 - 470